This practice set contains high-yield board review questions covering key concepts in Biology, Genetics & Bone Healing. Each clinical scenario is designed to test your diagnostic and management skills relevant to this subspecialty.
Question 2341
Topic: Biology, Genetics & Bone Healing
A 5-year-old girl with severe Osteogenesis Imperfecta (OI) is receiving intravenous pamidronate infusions to increase bone mineral density and reduce fracture frequency. Which of the following best describes the molecular mechanism of action of this medication?
Correct Answer & Explanation
. Inhibits farnesyl pyrophosphate (FPP) synthase in the mevalonate pathway
Explanation
Pamidronate is a nitrogen-containing bisphosphonate. It works by inhibiting farnesyl pyrophosphate (FPP) synthase in the mevalonate pathway, which leads to osteoclast apoptosis and reduced bone resorption.
Question 2342
Topic: Biology, Genetics & Bone Healing
A 12-year-old with multiple fractures has a bone biopsy that demonstrates a distinctive 'fish-scale' lamellation pattern under polarized light microscopy. The patient has shown no clinical improvement with prolonged bisphosphonate therapy. This presentation is most consistent with a mutation in which gene?
Correct Answer & Explanation
. IFITM5
Explanation
OI Type VI is caused by a mutation in the SERPINF1 gene, which encodes pigment epithelium-derived factor (PEDF). It is characterized histologically by a 'fish-scale' pattern of bone lamellation and typically does not respond to bisphosphonates.
Question 2343
Topic: Biology, Genetics & Bone Healing
A 4-year-old boy with SMA is prescribed Risdiplam. Which of the following accurately describes the administration and mechanism of this medication?
Correct Answer & Explanation
. Oral administration; small molecule modifier of SMN2 pre-mRNA splicing
Explanation
Risdiplam is an orally administered small molecule that modifies the splicing of the SMN2 pre-mRNA, leading to an increased concentration of functional full-length SMN protein.
Question 2344
Topic: Biology, Genetics & Bone Healing
A 2-year-old boy with OI type III receives his first intravenous infusion of pamidronate. Within 24 hours, he develops a fever of 38.5°C, myalgia, and vomiting. What is the most appropriate management of these symptoms?
Correct Answer & Explanation
. Supportive care with antipyretics, as this is a common first-dose acute phase reaction
Explanation
The 'acute phase reaction' is very common (up to 70-80%) after the first infusion of nitrogen-containing bisphosphonates like pamidronate. It consists of fever, myalgias, and flu-like symptoms, which are self-limiting and managed with supportive care.
Question 2345
Topic: Biology, Genetics & Bone Healing
Which of the following cellular processes accurately describes how a fracture heals in a patient with classical Osteogenesis Imperfecta (Type I, III, or IV)?
Correct Answer & Explanation
. Fracture healing occurs at a normal rate with normal callus formation, but the resulting bone is structurally inferior.
Explanation
In OI, the physiological cascade of fracture healing and callus formation occurs at a normal rate. However, because the collagen matrix is defective (either quantitatively or qualitatively), the newly formed bone remains structurally inferior and prone to re-fracture.
Question 2346
Topic: Biology, Genetics & Bone Healing
A 6-month-old infant presents with multiple fractures of varying ages, blue sclerae, and generalized osteopenia. Genetic testing reveals a mutation in the COL1A1 gene. Which of the following is the primary mechanism of action of the most commonly prescribed class of medications (bisphosphonates) used to treat this condition?
Correct Answer & Explanation
. Inhibition of osteoclast-mediated bone resorption
Explanation
Osteogenesis Imperfecta (OI) is treated medically with bisphosphonates (e.g., pamidronate or zoledronic acid). Bisphosphonates are analogues of inorganic pyrophosphate that bind to hydroxyapatite and function primarily by inhibiting osteoclast-mediated bone resorption, thereby increasing bone mineral density and decreasing the fracture rate.
Question 2347
Topic: Biology, Genetics & Bone Healing
A 4-year-old child with Osteogenesis Imperfecta (OI) type III is treated with intravenous pamidronate. What is the primary cellular mechanism of action by which this medication improves bone density and reduces fracture burden in this patient population?
Correct Answer & Explanation
. Inhibition of osteoclast-mediated bone resorption
Explanation
Bisphosphonates (such as pamidronate) are the medical treatment of choice for moderate to severe Osteogenesis Imperfecta. They function by inhibiting osteoclast activity and inducing osteoclast apoptosis, thereby decreasing bone resorption. This leaves osteoblast activity unopposed, increasing bone volume and density, though it does not correct the underlying genetic defect in Type I collagen synthesis.
Question 2348
Topic: Biology, Genetics & Bone Healing
A 65-year-old female on long-term alendronate therapy for osteoporosis presents with atraumatic thigh pain. Radiographs demonstrate focal lateral cortical thickening of the subtrochanteric femur with a transverse radiolucent line. Which of the following is the primary pathophysiologic mechanism leading to this atypical femur fracture (AFF)?
Correct Answer & Explanation
. Severe suppression of targeted osteoclastic bone remodeling leading to accumulation of microdamage
Explanation
Bisphosphonates profoundly suppress osteoclast function and apoptosis. Prolonged use (typically > 5 years) severely impairs targeted bone remodeling. Normally, microcracks from daily stress are repaired by basic multicellular units (BMUs). Suppressed remodeling allows these microcracks to accumulate, particularly on the tensile side of the femur (lateral cortex), eventually coalescing into an atypical femur fracture.
Question 2349
Topic: Biology, Genetics & Bone Healing
A neonate is evaluated for short-limbed dwarfism, a 'hitchhiker' thumb, clubfeet, and swelling of the external ear (cauliflower ear). This condition is inherited in an autosomal recessive manner. What is the underlying pathophysiologic defect?
Correct Answer & Explanation
. Defective intracellular transport of sulfate
Explanation
Diastrophic dysplasia is caused by a mutation in the SLC26A2 gene, leading to a defect in the sulfate transport system and resulting in undersulfated proteoglycans in cartilage.
Question 2350
Topic: Biology, Genetics & Bone Healing
A 12-year-old girl is noted to have excessive shoulder mobility, allowing her to touch her shoulders together anteriorly. She also has delayed eruption of secondary teeth. A mutation in which of the following transcription factors is responsible?
Correct Answer & Explanation
. RUNX2 (CBFA1)
Explanation
Cleidocranial dysplasia is caused by a mutation in RUNX2 (CBFA1), a master transcription factor for osteoblast differentiation. It is characterized by absent or hypoplastic clavicles and delayed cranial suture closure.
Question 2351
Topic: Biology, Genetics & Bone Healing
A 35-year-old woman presents with a large, lytic, epiphyseal lesion of the distal femur that extends to the subchondral bone. Biopsy confirms a Giant Cell Tumor of bone. Medical management with denosumab is planned. Denosumab targets which of the following?
Correct Answer & Explanation
. RANK ligand (RANKL)
Explanation
Denosumab is a monoclonal antibody that binds to RANKL, preventing it from activating the RANK receptor on osteoclast precursors. This inhibits osteoclast-mediated bone destruction in giant cell tumors.
Question 2352
Topic: Biology, Genetics & Bone Healing
A 32-year-old female presents with knee pain. Radiographs show an eccentric, lytic lesion in the distal femoral epiphysis reaching the subchondral bone. Biopsy confirms Giant Cell Tumor of Bone. When utilizing Denosumab for unresectable disease, what is the specific molecular target?
Correct Answer & Explanation
. RANKL expressed on the neoplastic mononuclear stromal cells
Explanation
In a Giant Cell Tumor, the neoplastic cells are the mononuclear stromal cells, which express RANK Ligand (RANKL). Denosumab is a monoclonal antibody that binds to this RANKL, inhibiting the recruitment and activation of the reactive osteoclast-like giant cells.
Question 2353
Topic: Biology, Genetics & Bone Healing
A 7-year-old boy presents with a waddling gait, bilateral knee pain, and mild short stature. Lateral knee radiographs demonstrate a classic "double-layer" patella. A diagnosis of Multiple Epiphyseal Dysplasia (MED) is suspected. A mutation in which gene is most commonly implicated?
Correct Answer & Explanation
. COMP
Explanation
Mutations in COMP (Cartilage Oligomeric Matrix Protein) are the most common cause of Multiple Epiphyseal Dysplasia. A double-layer patella on a lateral knee radiograph is highly characteristic of MED.
Question 2354
Topic: Biology, Genetics & Bone Healing
An 8-year-old girl is referred for evaluation of unusually delayed tooth eruption. On examination, she is noted to have a large head, delayed closure of cranial sutures, and she is able to easily bring her shoulders together anteriorly. Which genetic mutation is highly characteristic of this condition?
Correct Answer & Explanation
. RUNX2 (CBFA1)
Explanation
The patient has Cleidocranial Dysplasia, typified by hypoplastic or absent clavicles, delayed suture closure, and retained deciduous teeth. It is an autosomal dominant condition caused by mutations in RUNX2 (also known as CBFA1), a crucial transcription factor for osteoblast differentiation.
Question 2355
Topic: Biology, Genetics & Bone Healing
A 32-year-old female presents with knee pain. Radiographs demonstrate an eccentric, lytic, epiphyseal-metaphyseal lesion in the proximal tibia extending to the subchondral bone. Histopathology reveals abundant multinucleated giant cells distributed uniformly among mononuclear stromal cells. The neoplastic mononuclear cells in this tumor typically express high levels of which molecule to drive local bone destruction?
Correct Answer & Explanation
. Receptor activator of nuclear factor kappa-B ligand (RANKL)
Explanation
In a Giant Cell Tumor of bone, the neoplastic cells are the mononuclear stromal cells, which express high levels of RANKL. This recruits and stimulates normal host osteoclast precursors to form the characteristic multinucleated giant cells, leading to aggressive bone resorption.
Question 2356
Topic: Biology, Genetics & Bone Healing
A 12-year-old boy presents with an unusual ability to appose his shoulders anteriorly across his chest. Examination reveals an open anterior fontanelle, delayed eruption of his secondary dentition, and a somewhat prominent forehead. Radiographs show hypoplasia of the clavicles. Which essential transcription factor for osteoblast differentiation is mutated in this condition?
Correct Answer & Explanation
. RUNX2 (CBFA1)
Explanation
The patient has Cleidocranial Dysplasia, characterized by hypoplastic/absent clavicles, delayed suture closure, and dental anomalies. It is an autosomal dominant condition caused by a mutation in RUNX2 (CBFA1), a master transcription factor essential for osteoblast differentiation.
Question 2357
Topic: Biology, Genetics & Bone Healing
A 30-year-old female presents with mechanical knee pain. Imaging reveals an eccentric, purely lytic epiphyseal lesion of the distal femur extending to the subchondral bone. Biopsy confirms numerous multinucleated giant cells. Which of the following targeted systemic therapies is indicated for unresectable forms of this disease?
Correct Answer & Explanation
. Denosumab
Explanation
Giant Cell Tumor (GCT) of bone is driven by RANKL-secreting stromal cells that recruit osteoclast-like giant cells. Denosumab, a monoclonal antibody against RANKL, is highly effective for unresectable or recurrent GCTs.
Question 2358
Topic: Biology, Genetics & Bone Healing
A 9-year-old child presents with a waddling gait, bilateral knee pain, and short stature. Radiographs demonstrate small, irregular, fragmented epiphyses and a characteristic "double-layered" patella. A mutation in which of the following genes is most highly associated with this specific classic presentation?
Correct Answer & Explanation
. COMP
Explanation
Multiple Epiphyseal Dysplasia (MED) commonly presents with delayed, irregular ossification of the epiphyses. The finding of a 'double-layered' patella on a lateral radiograph is virtually pathognomonic and is classically associated with mutations in the COMP gene.
Question 2359
Topic: Biology, Genetics & Bone Healing
A 35-year-old woman presents with a lytic lesion in the distal femur. Biopsy reveals a benign, locally aggressive tumor characterized by mononuclear stromal cells and numerous multinucleated giant cells. Which of the following describes the cellular target of denosumab in the medical management of this tumor?
Correct Answer & Explanation
. It binds to RANKL expressed by the neoplastic mononuclear stromal cells
Explanation
In Giant Cell Tumor of bone, the mononuclear stromal cells are the true neoplastic cells and heavily express RANKL. Denosumab is a monoclonal antibody that binds to RANKL, preventing it from activating RANK on the osteoclast-like giant cells, thereby reducing bone resorption.
Question 2360
Topic: Biology, Genetics & Bone Healing
A newborn is noted to have a large anterior fontanelle, midface hypoplasia, and excessive mobility of the shoulders, allowing them to be opposed anteriorly. A mutation in the RUNX2 (CBFA1) gene is suspected. What is the primary role of the protein encoded by this gene?
Correct Answer & Explanation
. It is a master transcription factor for osteoblast differentiation
Explanation
Cleidocranial dysplasia is caused by a mutation in RUNX2 (also known as CBFA1). RUNX2 is a crucial transcription factor required for the commitment and differentiation of mesenchymal stem cells into the osteoblast lineage.
Test Yourself
Switch to an interactive, timed exam simulation to truly master this topic.